US biotech major Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new ...

San Diego-based iBio, an AI-driven innovator of precision antibody therapies, has announced a licensing agreement with ...

Harvard University has filed a lawsuit against the US government after more than $2 billion in federal research funding was ...

US clinical-stage biotech Halda Therapeutics today announced that Dr Eyal Attar has joined the company as chief medical ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

A biotech company integrating of AI and synthetic biology to design safer and more effective antibody therapeutics.

A clinical-stage biotech company developing first-in-class targeted and immune-mediated therapeutics to fight cancer.

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...

Galapagos (Euronext: GLPG) has appointed Henry Gosebruch as chief executive of its upcoming oncology spin-off, marking a ...

Japan’s Ono Pharmaceutical and privately-held US firm Jorna Therapeutics are ready to go in a research collaboration ...

Zymeworks (Nasdaq: ZYME), a clinical-stage biotech developing antibody-based therapies for cancer and immune diseases, has ...

Physician attitudes toward patient choice between the use of biologics and biosimilars vary widely across global markets, ...